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Abstract
Background: Skin cancer is the most common malignancy in the white population worldwide. In Brazil, the
National Cancer Institute (INCA) estimates that in 2010 there will be 119,780 and 5,930 new cases of non-
melanoma skin cancer and melanoma, respectively. The aim of this study was to evaluate the use of a mobile unit
in the diagnosis and treatment of skin cancer in several poor regions of Brazil.
Methods: The diagnosis of skin cancer was accomplished through active medical screening in the prevention
Mobile Unit (MU) of Barretos Cancer Hospital (BCH). The study population consisted of patients examined in the
MU between 2004 and 2007, and their suspicious lesions were subjected to histopathological evaluation. Data
were collected prospectively from standardized forms and analyzed.
Results: During the screening, 17,857 consultations were carried out. A total of 2012 (11.2%) cases of skin cancer
were diagnosed. The predominant histological type reported was basal cell carcinoma (n = 1,642 or 81.6%),
followed by squamous cell carcinoma (n = 303 or 15.1%), Bowen’s disease (n = 25 or 1.2%), malignant melanoma
(n = 23 or 1.1%), basosquamous cell carcinoma (n = 3 or 0.1%), miscellaneous lesions (12 or 0.6%), and metatypical
carcinoma (n = 4 or 0.2%). Only 0.6% of lesions were stage III. There were no stage IV non-melanoma skin lesions,
as well as no melanomas stages III and IV, found.
Conclusions: It was observed that the MU can be a useful tool for early skin cancer diagnosis and treatment. This
program probably is important, especially in developing countries with inadequate public health systems and
social inequality.
Background
Skin cancer is the most common malignancy in the
white population worldwide [1]. The 2 most common
histopathological variants are basal cell carcinoma
(BCC) and squamous cell carcinoma (SCC); despite
their low mortality rates, these tumors can induce ser-
ious sequelae as a consequence of surgery [1]. The third
most common skin cancer type, malignant melanoma,
has a more aggressive behavior and consequently a
poorer prognosis; malignant melanoma accounts for
approximately 75% of all deaths from skin cancer [2].
There is strong evidence to date that whole-body clin-
ical skin examination reduces the incidence of thick
melanoma and, consequently, screening would reduce
melanoma mortality [3]. Melanoma thickness at presen-
tation is significantly associated with educational level
[4]. In Brazil, the National Cancer Institute (INCA) esti-
mates that in 2010 there will be 119,780 and 5,930 new
cases of non-melanoma skin cancer and melanoma,
respectively, which corresponds to 25% of all cancers for
that period. The median 5-year survival rate for patients
with melanoma is estimated at 73% in developed coun-
tries; however, it is only 56% in developing countries [5],
reflecting their delayed diagnosis. Although the mortality
from non-melanoma skin cancer is very low [5], impor-
tant deformations can be consequences of the treatment.
The Brazilian Ministry of Health encourages the Brazilian
population to avoid the sun during some periods of the day
and to carefully examine their skin [5]. Few studies have
reported the use of a mobile unit in the primary prevention
of skin cancer [6,7]. Therefore, we did not find evidence of
the use of a mobile unit equipped with a surgical room for
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the treatment of skin lesions. The aim of this study was to
evaluate the use of a mobile unit in the diagnosis and treat-
ment of skin cancer in several regions of Brazil.
Methods
The diagnosis of skin cancer was accomplished through
active medical search in the prevention Mobile Unit
(MU) of Barretos Cancer Hospital (BCH). The study
population consisted of 17,857 pre-selected patients with
suspected cancer of the skin who were examined in the
MU between 2004 and 2007 to confirm the diagnosis.
The trailer portion of the MU was adapted and
equipped for clinical and surgical procedures. The design
of the truckers’ trailer accommodations and facilities was
totally developed by a BCH group. The mobile unit team
is composed of a clinical or surgical oncologist, a nurse, 3
nursing assistants, and a driver, and this team is able to
daily perform 40 physical examinations of the skin (with
surgery and cryotherapy). In this study, we used the MU
only for skin cancer prevention, diagnosis, and treatment.
The MU is intended to travel to small cities and rural
areas in several States of Brazil, including the Amazonas
region. The MU visit is normally preceded by a phone
call from a health care professional from the Department
of Prevention of BCH; this individual makes the first con-
tact with local authorities of the cities to be visited and
plans the training of nurses and social assistants from
these cities in the BCH. These local nurses are trained all
day to identify suspicious lesions for skin cancer by the
nurses and a physician from Barretos Cancer Hospital
with experience in skin cancer screening. Specific confer-
ences are offered in order to exemplify the different types
of the more frequent skin lesions, and didactic materials
(e.g., images CD, banners, leaflets and brochures) are
given to support the educational training. These nurses
are also responsible for speaking with the clinicians in
these cities to convince them about the importance of
their participation in the prevention activities and also
for closely assisting the nurses’ triage. In addition, they
are encouraged to principally invite the underprivileged
people that live in the suburbs or in rural areas and to
inform them that all of the procedures related to the can-
cer prevention and treatment are free of charge.
Patients examined in this study were evaluated in the
MU, and their suspicious lesions were subjected to his-
topathological evaluation, local resection with margins,
or local resection with skin flaps or use of a skin graft.
Patients with large lesions or patients with a need for
complex surgical procedures were scheduled to be
examined and treated at BCH. The samples collected
were properly identified and forwarded to the Pathology
Department of BCH, where reports were ascertained.
Precursor lesions were treated with cryotherapy in the
MU.
One copy of the histopathological results was mailed
to each patient and another to the cities’ nurses involved
in this project. A secretary in the Prevention Depart-
ment of BCH scheduled a consultation by telephone.
The patients with a skin cancer diagnosis who only
underwent biopsy or had involvement of the surgical
margins were followed to radiotherapy or surgery at the
BCH. The patients who did not respond to the call for
BCH treatment received a second invitation. If the
patients did not respond to this new invitation, a third
letter was sent to the patient and simultaneously to the
public health authorities of the municipality, informing
them of the need to do a medical consultation in
another Institution.
Data from patients cared for in the MU were collected
prospectively from standardized forms at the Depart-
ment of Prevention and recorded. When a case of skin
cancer was diagnosed, the information was sent to the
Hospital Cancer Registry of BCH. The variables evalu-
ated were as follows: gender, local of residence, year of
first attendance, age, schooling, pathologic diagnosis,
and stage [8]. The number of lesions excised, the sizes
of the lesions, the location of the major lesion, the type
of surgery, and the type of additional therapy (surgery
or radiotherapy) were analyzed only for the MU patients
who underwent surgery.
Descriptive analysis was performed using frequencies
and percentages, as well as measures of central tendency
and dispersion (mean, median, minimum and maximum
values).
The clinical and pathological data were collected from
the medical records of the patients. Data were stored
and statistical indexes calculated in a database set up in
the software SPSS for Windows 17.0 (Inc., Chicago, IL,
USA).
The Ethics Committee of the Barretos Cancer Hospi-
tal approved this study protocol. All the Consent
informed terms were signed and are currently archived
in Prevention Cancer Unit under supervision of the
local Ethical Committee.
Results
During the 4 years of skin lesion screening, 17,857 con-
sultations were carried out and 3,005 biopsies or sur-
geries were performed. From this, a total of 2012
(11.2%) cases of skin cancer were diagnosed in a slight
majority of women (51.1%); 85.6% of the patients were
aged 40-79 years (Table 1). The educational level of the
patients was predominantly low: 87.5% were illiterate or
had completed 8 years of basic study, 7.7% had com-
pleted between 8 and 12 years of study, and 4.8% had
incomplete or complete higher education.
The majority of the patients (82%) with skin cancer
had resection of the lesion performed in the MU, and
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74.6% had only one suspicious lesion that was surgically
removed. The remaining patients had 2 or more skin
lesions. Such lesions were detected mostly in the head
and neck region (78.7%). Lesions on the trunk, upper
limbs, and lower limbs appeared in 12.7%, 7.8%, and
0.8% of cases, respectively.
Of the total number of diagnosed patients who had
screening procedures performed in the MU, only a
biopsy was performed in 230 (11.4%) of the patients.
The remaining 132 (6.6%) patients who had no surgical
procedure performed in the MU were sent to BCH for
reasons such as a high-risk medical condition, advanced
age, a very large lesion for which biopsy is not indicated,
or a preference for treatment in our hospital. Unfortu-
nately, of these 230 patients, 17.9% did not respond to
the call for treatment. The biopsy procedure was used
for large lesions, for those that would cause difficulty in
reconstruction, for lesions in cartilage, or for lesions in
patients submitted to adjuvant radiotherapy. For 1,113
(55.3%) lesions, we performed resection and simple
suture; for 645 (32.1%) lesions, we performed resection
with flap rotation; and for 24 (1.2%) lesions, we per-
formed resection and skin grafting. Of the 3,005 suspi-
cious lesions analyzed, 67% showed evidence of cancer
on histopathological examination, and the predominant
histological type reported was basal cell carcinoma (n =
1,642 or 81.6%) (Table 1). Our findings show that the
sensitivity rate (cases of skin cancer per suspicious
lesions analyzed) ranged from 0% to 61% in the cities
visited.
The clinical stage or the stage of cancer development
(amount or spread of cancer in the body) of the lesions
was evaluated. The vast majority of non-melanoma skin
cancers (93.9%) were stages 0 and I; 5.5% of cancers
were stage II and 0.6% of cancers were stage III. For
melanomas, 88.8% were stages 0 and I and 11.2% were
stage II. The median thickness of these lesions was 0.9
mm (range: 0.5 to 4.0 mm). There were no stage IV
non-melanoma skin lesions, as well as no melanoma
stages III and IV, found.
Discussion
Early diagnosis of skin cancer is crucial for obtaining the
best treatment results, improving the prognosis, and,
most importantly, increasing the quality of life of the
patient. However, there is no robust evidence to ascer-
tain whether there is a decrease in mortality due to reg-
ular physical examination of the skin [7]. Considering,
e.g., melanoma, the diagnosis of incipient lesions, up to
1.00 mm thick, provides an excellent survival rate of
97% after 5 years [9]; but the survival rate is only 7% to
19% if stage IV lesions are found [10]. More recent data
show that the one-year survival rate is 33% in patients
with metastatic melanomas (stage IV) [9]. Conversely,
and despite the low rates of mortality and low potential
for metastasis, early diagnosis of non-melanoma skin
cancer is also essential to reducing the cost of treatment
and the associated consequences [11,12].
Importantly, we observed in this study a large propor-
tion of lesions of more than 2.0 cm in diameter among
the non-melanoma cancers (129 or 6.5%), as well as
melanomas that were 0.75 mm to 1.5 mm in thickness
(3 or 13.0%). This may reflect, in part, the lack of public
health cancer prevention programs, which creates many
barriers to medical evaluation and care. The Fundação
Oncocentro de São Paulo - FOSP (São Paulo Cancer
Foundation) is a Government Foundation with a data-
base of the hospital cancer registry of São Paulo State.
The records show that during the same time period
(2004 to 2007), 9.4% of non-melanoma skin cancers
were more than 2.0 cm in diameter [13]. Although there
is a concerted effort to provide good health services
equally to all citizens, this is not the reality in this coun-
try. This is because there are regional and interstate dif-
ferences in health care.
Table 1 Case distribution of non-melanoma and
melanoma skin cancers in patients served by the Mobile
Unit
Variable Category Screening n° (%)
Gender Male 983 (48.9)
Female 1,029 (51.1)
Age (years) < 40 92 (4.6)
40 - 59 625 (31.1)
60 - 69 573 (28.5)
70 - 79 525 (26.1)
≥ 80 197 (9.8)
Origin state São Paulo 1,086 (53.7)
Mato Grosso 500 (24.9)
Mato Grosso Sul 195 (9.7)
Rondônia 94 (4.7)
Minas Gerais 84 (4.2)
Goiás 53 (2.6)
Clinical Stage 0 40 (2.0)
I 1840 (91.5)
II 110 (5.5)
III 13 (0.6)
IV 0 (0)
X 9 (0.4)
Diagnosis BCC 1,642 (81.6)
SCC 303 (15.1)
Melanoma 23 (1.1)
Metatypical Cancer 4 (0.2)
Other 12 (0.6)
Bowen’s disease 25 (1.2)
Basosquamous CC 3 (0.1)
Total 2,012
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Use of a mobile unit for the early diagnosis of other
cancers, such as breast and cervical cancer, has been
used for decades in many countries [14] and has shown
good results in remote and rural Brazilian areas
[6,7,15-17]. This strategy is still being used for breast
cancer screening in developed countries [18]. The UMP
of BCH is the exclusive initiative to “catch up” patients
in remote areas in Brazil. To our knowledge, it is also
unique anywhere in the world to conduct small and
medium skin surgeries in an MU. Few reports of the
use of an MU for skin cancer screening are found in
developed countries, probably due to a more well-devel-
oped health care structure and a population with better
information on means of preventing this cancer [5,19].
Since changes in the health care system are usually
slow, the use of an MU provides faster specialized medi-
cal care to the people with difficult access to health ser-
vices. At the same time, it provides the opportunity to
disseminate information about the importance of cancer
prevention. One good example of MU use in the indus-
trial field is the Senai Mobile Technical School. This
Brazilian government department developed programs
to prepare manpower in locations not served by fixed
schools. Its structure of mobile units allows for more
flexibility in attendance and a greater exchange between
the institution and local industries [20].
Even with little training time with the staff of the
Department of Prevention, the nurses in municipalities
have obtained reasonable results in the screening of sus-
picious lesions, with 2,012 positive cases in 17,857
assessments (11.3%).
The training of health care professionals is of para-
mount importance to the project. Possibly, teledermatol-
ogy is a feasible option for improving the project,
because of the huge distances in remote areas visited by
the MU [21-23]. We have also observed a great commit-
ment from the poorest populations of the cities visited,
especially in the Amazon region, where 73.9% of people
are illiterate or only have up to 8 years of schooling.
This commitment to the MU is a very welcomed situa-
tion, but it also indicates the lack of an adequate system
of public health in municipalities and states. In many
cities, people have anxiously remained waiting in close
proximity to the MU since very early in the morning to
be sure that a doctor will examine them. Sometimes,
they have stayed until almost midnight because they are
afraid that the MU would not remain another day in
that city.
In Brazil, 70% of the cities have less than 20,000 inhabi-
tants, and approximately 20 million inhabitants still live
in rural areas [24]. Dermatologists or general practi-
tioners with appropriate experience to identify early skin
cancer lesions are most likely not found in these areas,
explaining the reduction in cases of skin cancer diagnosis
and treatment in these populations. According to the
Brazilian Society of Dermatology, the vast majority of
dermatologists are in São Paulo State (32.8%). Some
States visited by the MU have only 0.1% of Brazilian der-
matologists; this means that there is only 1 dermatologist
for 306,609 inhabitants [25].
The skill of a well-trained medical oncologist prepared
to identify skin lesions and perform the surgical inci-
sions was well exemplified in our study: 67% of the
lesions surgically removed were categorized as cancer,
and importantly, 82% of the patients with skin cancer
had resection of the lesion at the MU. The false positive
rate was 33%, once 3,005 surgeries were performed..
Skin cancer prevention is cost-effective [26,27]. This is
an important issue to be discussed with governmental
public health authorities to improve the detection of
early stages of skin cancer. Potential barriers to hamper
the efficacy of skin cancer screening include the reduced
time to perform a screening during a regular physical
examination and the lack of a specific training program
for dermatologists to recognize lesions that are poten-
tially neoplastic [28]. In Brazil, only 74.1% of dermatolo-
gists completed a fellowship or have a specialist title [25].
Health care professionals, in general, do not counsel
patients regarding the prevention of skin cancer except
for dermatologists [29].
The Barretos Cancer Hospital overall mobile unit
(MU) cost is $566,181.17 USD. This cost represents sev-
eral components of the MU as follows: tractor truck
$205,882.35 USD; semi-trailer $58,823.53 USD; semi-
trailer modifications $235,294.11 USD; equipments
$58,823.53 USD, and marketing adhesives $7,357.65
USD. To carry out 800 to 1.000 monthly skin lesions
evaluations, MU have additional monthly costs with
professionals salary and taxes: one physician ($11,764.70
USD), one nurse ($2,115.32 USD), two nurse’s assistants
($864.85 USD), one typist ($630.00 USD) and 2 MU dri-
vers ($932.56 USD), resulting in an annual cost of
$217,258.52 USD.
Consumables costs for MU travel maintenance corre-
spond to $8,000.00 USD per month: fuel ($2,941.18
USD), toll ($352.94 USD), mechanic vehicle mainte-
nance ($4,705.88 USD). For staff’s accommodation and
meal during the travel and the monthly cost is $882.35
USD. All included, the monthly operational cost is
about $16,882.35 USD.
Public Health System fees for consultations/examina-
tions, biopsies and resection, are $5.88 USD, $8.30 USD
and $7.33 USD, respectively. The numbers of procedures
for the 2010 were 800 attendances monthly which corre-
spond to 800 consultations/examinations ($4,705.88 per
USD month), 172 biopsies ($1,429.92 USD per month)
and 24 resections ($179.02 USD per month). The total
annual income was $75,777.88 USD.
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Notice however that the same mobile unit that per-
forms the screening of skin cancer, also, performs
screening for cervical cancer (Pap smear) and prostate
cancer, attenuating the total costs.
Despite the high exposure to the solar rays, the Brazilian
population has lower incidences of melanoma and non-
melanoma skin cancer compared to the Australian popu-
lation [27]. A speculative reason for this difference could
be the high miscegenation of the Brazilian population,
which includes indigenous individuals and African descen-
dants, who live in these states and create protective char-
acteristics against skin cancer for many people. The other
European descendants choose to live in the south or
southeast of Brazil, where the weather is colder and there
is less sun exposure than in other regions of the country.
Unfortunately, we failed to encourage the participation
of local medical doctors in these efforts toward cancer
prevention. Alternatively, our strategy of having those
physicians invited by a nurse to participate in this pro-
ject may not be the most adequate recruitment strategy.
The lack of medical oncologists and dermatologists in
the visited cities, especially in smaller towns and rural
areas, was a major limitation of this project. This is prob-
ably due to the reduced value of medical remuneration
paid by governmental public health authorities, which
clearly encourages these professionals to work preferably
at private clinical services. This lack of doctors makes it
difficult to supervise the nurses’ triage of the patients.
Another limitation was the limited experience of nurses
in some municipalities. The rate of 11.3% of positive cases
among patients invited by nurses to undergo screening
ranged considerably. This is mainly due to the short train-
ing and lack of time some nurses in those municipalities
had to work on this project. To improve the quality of
patient selection in each city and to increase the rate of
cancer patients examined for lesions, the training of nurses
should gain more attention from the staff of the Barretos
Cancer Hospital. The lessons will be refurbished and the
supplied material will be restructured. These nurses will
also be invited to monitor the operations performed by
the mobile unit, which may include following the proce-
dures and consultations with a specialist.
Is important to say that this is a pre-selected popula-
tion, so these results cannot be established on the preva-
lence or distribution rates of skin cancers in the
Brazilian general population.
Despite these limitations, we were able to diagnose
2012 cases of skin cancer and more than 80% of these
patients were operated on in the MU.
Conclusions
It was observed that the MU can be a useful tool for the
screening and treatment of skin lesions, providing a
quick and effective solution for reaching populations in
remote areas, rural municipalities, or regions with low
access to a public health system. This is an effective
method of underscoring the necessity to improve assis-
tance to underprivileged populations to minimize the
occurrence of advanced cases of skin cancer in a coun-
try with an inadequate health care system.
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